| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/05/2004 | WO2002100886A8 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 02/05/2004 | US20040024217 Synthesis of piperidine and piperazine compounds as CCR5 antagonists |
| 02/05/2004 | US20040024211 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes |
| 02/05/2004 | US20040024210 New compounds |
| 02/05/2004 | US20040024209 Drugs such as 4-(3-Bromo-4-fluorobenzyl)morpholine used as viricides against herpes viruses |
| 02/05/2004 | US20040024206 Pyrimidine compounds |
| 02/05/2004 | US20040024203 Imines such as 4-(3-((3-(2,4-dichlorophenyl)propanoyl)amino)-1-(3-(morpholin-4-yl)propyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-5-yl)benzamide, administered for prophylaxis of Alzheimer's disease |
| 02/05/2004 | US20040024190 Viral polymerase inhibitors |
| 02/05/2004 | US20040024173 Water-compatible cationic epoxy compounds |
| 02/05/2004 | US20040024067 Deacetylase inhibitors |
| 02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
| 02/05/2004 | US20040024051 C10 heterosubstituted acetate taxanes |
| 02/05/2004 | US20040024040 Inhibitors of GSK-3 and uses thereof |
| 02/05/2004 | US20040024039 Having a steroid C17,20-lyase inhibitory activity; useful as prophylactic or therapeutic agent for prostate and breast cancers |
| 02/05/2004 | US20040024024 Inhibiting matrix metalloproteinase and aggrecanase activity; for treatment of strokes and neurodegenerative diseases |
| 02/05/2004 | US20040024023 1-Heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/05/2004 | US20040024017 Process for producing carbostyril derivatives |
| 02/05/2004 | US20040024014 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers |
| 02/05/2004 | US20040024010 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/05/2004 | US20040024000 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 02/05/2004 | US20040023999 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/05/2004 | US20040023996 Methods and compositions utilizing quinazolinones |
| 02/05/2004 | US20040023993 Diagnosis and treatment of anxiety, Down Syndrome, sleep, cognitive and seizure disorders, depression, overdose with benzodiazepine drugs, and enhancement of memory and alertness; gamma-aminobutyric acid (gaba) |
| 02/05/2004 | US20040023976 Treatment of gastrointestinal stromal tumors |
| 02/05/2004 | US20040023973 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof. |
| 02/05/2004 | US20040023968 Phthalazinone derivatives |
| 02/05/2004 | US20040023950 N-heterocyclic derivatives as NOS inhibitors |
| 02/05/2004 | US20040023945 Cyclic amp-specific phosphodiesterase inhibitors |
| 02/05/2004 | US20040023932 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the |
| 02/05/2004 | US20040023929 Small molecules for inhibition of function and drug delivery to leukocytes |
| 02/05/2004 | US20040023805 Substituted phenyluracils |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/05/2004 | US20040022854 Oral administration of proton pump inhibitor |
| 02/05/2004 | US20040022846 Reduced side-effects |
| 02/05/2004 | DE10234876A1 4-Trifluormethylpyrazolyl substituierte Pyridine und Pyrimidine 4-substituted pyridines and pyrimidines Trifluormethylpyrazolyl |
| 02/05/2004 | DE10234875A1 4-Trifluormethylpyrazolyl substituierte Pyridine und Pyrimidine 4-substituted pyridines and pyrimidines Trifluormethylpyrazolyl |
| 02/05/2004 | DE10234058A1 Neue substituierte Benzoesäureamide, deren Herstellung und deren Verwendung als Arzneimittel New substituted benzamides, their preparation and their use as medicaments |
| 02/05/2004 | CA2494668A1 Chemical compounds |
| 02/05/2004 | CA2494102A1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
| 02/05/2004 | CA2493924A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 02/04/2004 | EP1386920A1 Benzimidazolone derivatives |
| 02/04/2004 | EP1386915A1 Azole compounds, process for preparation of the same and use thereof |
| 02/04/2004 | EP1386913A1 Pyrrole derivative |
| 02/04/2004 | EP1386912A1 Cyclic amidine derivative |
| 02/04/2004 | EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors |
| 02/04/2004 | EP1385845A1 N-aroyl cyclic amines |
| 02/04/2004 | EP1385843A1 Arylindenopyridines with pde inhibiting activity |
| 02/04/2004 | EP1385842A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/04/2004 | EP1385840A1 Sulfonamides |
| 02/04/2004 | EP1385839A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/04/2004 | EP1385838A1 Piperazino-derivatives and their use as pde4 inhibitor |
| 02/04/2004 | EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/04/2004 | EP1385833A1 Triazinyl amide derivatives as angiogenesis inhibitors |
| 02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 02/04/2004 | EP1385824A2 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 02/04/2004 | EP1385823A1 Novel guanidino compounds |
| 02/04/2004 | EP1385818A2 Biurethane derivatives |
| 02/04/2004 | EP1385518A1 Benzimidazolone compounds |
| 02/04/2004 | EP1385507A1 Sulfonamides |
| 02/04/2004 | EP1385504A1 Method of inhibiting adhesion formation |
| 02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 02/04/2004 | EP1196409B1 Respiratory syncytial virus replication inhibitors |
| 02/04/2004 | EP1115697B1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 02/04/2004 | EP0983264B1 Method of manufacturing sertindole |
| 02/04/2004 | EP0813525B9 Benzamidine derivatives their preparation and their use as anti-coagulants |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473156A Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 02/04/2004 | CN1473154A Phthalazinone derivatives |
| 02/04/2004 | CN1473153A Hetero-anellated ortho-aminophenols |
| 02/04/2004 | CN1473043A Method for treating allergies using substituted pyrazoles |
| 02/04/2004 | CN1137090C New processes for preparing pesticidal intermediates |
| 02/03/2004 | US6686474 Reacting benzimidazole compound with m-chloroperoxybenzoic acid in a solvent selected from the group consisting of acetone and acetone/water mixture; raising the ph of the reaction mixture; crystals are separated |
| 02/03/2004 | US6686379 Salt form of pantoprazole |
| 02/03/2004 | US6686376 Methods and compounds for inhibiting MRP1 |
| 02/03/2004 | US6686372 Selective β3 adrenergic agonists |
| 02/03/2004 | US6686368 Inhibitors of factor Xa |
| 02/03/2004 | US6686367 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 02/03/2004 | US6686362 Indolinone derivatives |
| 02/03/2004 | US6686361 For therapy of anxiety, depression, and other psychogenic disorders |
| 02/03/2004 | US6686357 Benzimidazolo-piperidine compound |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686351 Compounds and methods for modulation of estrogen receptors |
| 02/03/2004 | US6686350 Cell adhesion inhibitors |
| 02/03/2004 | US6686347 Phthalazine derivatives for treating inflammatory diseases |
| 02/03/2004 | US6685617 4-(((-1-carboxy-2-(4-((2,6-dichlorobenzoyl)amine)phenyl)ethyl) amino)carbonyl)-3-oxo-3-thiazolidinebutanoic acid, used as antagonists for cellular adhesion molecules, and administered as antiinflammatory agents |
| 02/03/2004 | CA2092510C Crystalline forms of endo-2,3-dihydro-n-(8-methyl-8-azabicyclo-[3.2.1.]oct-3-yl)-2-oxo-1h-benzimidazole-1-carboxamide hydrochloride monohydrate and of endo-3 ethyl-2,3-dihydro-n-(8-methyl-8-azabicyclo[3.2.1.]oct-3-yl)-2-oxo-1h-benzimidazole-1-carboxamide hydrochloride monohydrate |
| 01/29/2004 | WO2004009584A1 Novel p-glycoprotein inhibitor, method for preparing same and oral composition comprising same |
| 01/29/2004 | WO2004009583A2 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 01/29/2004 | WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | WO2004009562A1 Substituted triazine kinase inhibitors |
| 01/29/2004 | WO2004009558A2 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
| 01/29/2004 | WO2004009557A1 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 01/29/2004 | WO2004009556A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 01/29/2004 | WO2004009555A1 5-substituted isoquinoline derivative |
| 01/29/2004 | WO2004009552A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | WO2004009551A1 Process for producing 2-substituted pyridine derivative |
| 01/29/2004 | WO2004009549A2 Piperidines useful for the treatment of central nervous system disorders |
| 01/29/2004 | WO2004009548A1 1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/29/2004 | WO2004009547A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | WO2004009546A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |